85%Confidence
0Views
FDASource
2026-04-11Date
Summary
Strides Pharma's Class II recall for Children's Ibuprofen due to foreign particles indicates contamination risks in a pediatric OTC product, which could lead to consumer distrust and regulatory action. This may impact Taro Pharmaceuticals' brand reputation and sales in the children's medication segment.
Actionable: Advise retailers to pull affected batches and promote alternative pediatric ibuprofen brands to maintain sales.
AI Confidence: 85%
Data Points
firmSTRIDES PHARMA INC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now